Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies: a pharmacovigilance analysis
Donald C. Moore, Joseph B. Elmes, Justin Arnall, Scott A. Strassels, Jai N. Patel
Topics & Concepts
DaratumumabMedicineAdverse Event Reporting SystemPharmacovigilanceHBsAgHepatitis B virusInternal medicineAdverse effectVirologyMonoclonal antibodyOncologyImmunologyAntibodyVirusHepatitis B Virus StudiesDrug-Induced Hepatotoxicity and ProtectionPharmacovigilance and Adverse Drug Reactions